We are live on
!
Find out more
LIP
Liontrust Investment Partners Portfolio holdings
AUM
$5.86B
1-Year Est. Return
23.75%
This Fund
S&P 500
This Quarter
Est. Return
+7.25%
1 Year Est. Return
+23.75%
3 Year Est. Return
+74.7%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.84B
AUM Growth
-$145M
(-2.1%)
Cap. Flow
-$428M
Cap. Flow
% of AUM
-6.25%
Top 10 Holdings %
Top 10 Hldgs %
30.27%
Holding
216
New
18
Increased
66
Reduced
88
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAVA Group
CAVA
|
+$54.2M |
| 2 |
TTAN
ServiceTitan Inc
TTAN
|
+$29.9M |
| 3 |
Intuitive Surgical
ISRG
|
+$27.4M |
| 4 |
Veralto
VLTO
|
+$20.6M |
| 5 |
Apple
AAPL
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$92.2M |
| 2 |
PayPal
PYPL
|
+$89.7M |
| 3 |
Transmedics
TMDX
|
+$70.2M |
| 4 |
ServiceNow
NOW
|
+$58.2M |
| 5 |
Seagate
STX
|
+$36.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.16% |
| 2 | Healthcare | 16.34% |
| 3 | Financials | 15.62% |
| 4 | Industrials | 11.97% |
| 5 | Communication Services | 10.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Qfin Holdings
QFIN
$1.56B
| – | – |
-6,989
| Closed | -$303K |
|
202
Recursion Pharmaceuticals
RXRX
$1.8B
| – | – |
-702,386
| Closed | -$3.55M |
|
203
Starbucks
SBUX
$122B
| – | – |
-105,830
| Closed | -$9.7M |
|
204
Sherwin-Williams
SHW
$88.5B
| – | – |
-37,610
| Closed | -$12.9M |
|
205
Molson Coors Class B
TAP
$7.83B
| – | – |
-9,981
| Closed | -$480K |
|
|
206
Transmedics
TMDX
$3.1B
| – | – |
-523,748
| Closed | -$70.2M |
|
207
Winmark
WINA
$1.33B
| – | – |
-4,334
| Closed | -$1.64M |
|
208
WIX.com
WIX
$2.79B
| – | – |
-23,400
| Closed | -$3.71M |
|
|
209
West Pharmaceutical
WST
$24.7B
| – | – |
-421,601
| Closed | -$92.2M |
|
210
XP
XP
$8.01B
| – | – |
-22,000
| Closed | -$444K |
|
211
Zimmer Biomet
ZBH
$18.5B
| – | – |
-10,784
| Closed | -$984K |
|
212
Zillow
ZG
$7.71B
| – | – |
-5,095
| Closed | -$349K |
|
213
Zscaler
ZS
$28.9B
| – | – |
-41,425
| Closed | -$13M |
|
214
Zoetis
ZTS
$31.1B
| – | – |
-14,691
| Closed | -$2.29M |
|
|
CRCL
215
Circle Internet Group
CRCL
$18.1B
| – | – |
-2,818
| Closed | -$511K |
|
|
CHYM
216
Chime Financial
CHYM
$12B
| – | – |
-20,137
| Closed | -$695K |
|
Similar funds
CIC
SC
BSL
MWM
WAM
CGPCS
AL
PP
Liontrust Investment Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Liontrust Investment Partners held 216 positions worth $6.84B, down 2.1% from $6.99B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Liontrust Investment Partners withdrew a net $428M in Q3 2025, closing 27 positions and reducing 88 holdings. Its most notable exit was West Pharmaceutical, an estimated $92.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Liontrust Investment Partners opened a new position in CAVA Group worth $43.2M.
- Liontrust Investment Partners's largest Q3 2025 buy was CAVA Group: 714,934 shares worth $43.2M.
- Liontrust Investment Partners added most to ServiceTitan Inc in Q3 2025, an estimated $29.9M increase.
- Liontrust Investment Partners's biggest Q3 2025 reduction was PayPal, cutting an estimated $89.7M.
- Liontrust Investment Partners fully exited West Pharmaceutical in Q3 2025, selling an estimated $92.2M.
- Liontrust Investment Partners's ten largest holdings make up 30% of its $6.84B portfolio in Q3 2025.
- Liontrust Investment Partners opened 18 new positions and closed 27 in Q3 2025.
- Liontrust Investment Partners's portfolio value fell 2.1% quarter-over-quarter to $6.84B.
Based on Liontrust Investment Partners's 13F filing for Q3 2025, filed 24 Nov 2025.